Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 188

1.

Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study.

Tarantino L, Busto G, Nasto A, Fristachi R, Cacace L, Talamo M, Accardo C, Bortone S, Gallo P, Tarantino P, Nasto RA, Di Minno MN, Ambrosino P.

World J Gastroenterol. 2017 Feb 7;23(5):906-918. doi: 10.3748/wjg.v23.i5.906.

2.

The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature.

Di Minno MN, Ambrosino P, Di Minno A, Tremoli E, Di Minno G.

Ann Med. 2017 Jan 13:1-14. doi: 10.1080/07853890.2016.1268710. [Epub ahead of print]

PMID:
28084107
3.

Efficacy and safety of extended thromboprophylaxis for medically ill patients. A meta-analysis of randomised controlled trials.

Dentali F, Mumoli N, Prisco D, Fontanella A, Di Minno MN.

Thromb Haemost. 2017 Jan 12. doi: 10.1160/TH16-08-0595. [Epub ahead of print]

PMID:
28078350
4.

8-Hydroxy-2-deoxyguanosine levels and heart failure: A systematic review and meta-analysis of the literature.

Di Minno A, Turnu L, Porro B, Squellerio I, Cavalca V, Tremoli E, Di Minno MN.

Nutr Metab Cardiovasc Dis. 2016 Nov 20. pii: S0939-4753(16)30194-6. doi: 10.1016/j.numecd.2016.10.009. [Epub ahead of print]

PMID:
28065503
5.

Efficacy and safety of extended antithrombotic prophylaxis in elderly medically ill patients.

Dentali F, Mumoli N, Fontanella A, Di Minno MN.

Eur Respir J. 2017 Jan 4;49(1). pii: 1601887. doi: 10.1183/13993003.01887-2016. No abstract available.

PMID:
28052958
6.

Recombinant activated factor VII (eptacog alfa activated, NovoSeven ® ) in patients with rare congenital bleeding disorders. A systematic review on its use in surgical procedures.

Di Minno MN, Ambrosino P, Myasoedova VA, Amato M, Ventre I, Tremoli E, Di Minno A.

Curr Pharm Des. 2016 Dec 30. [Epub ahead of print]

PMID:
28034354
7.

WITHDRAWN: Could some epigenetic modifications hold the key to opposing the metabolic syndrome?

Tarantino G, Di Minno MN, Finelli C.

Oncotarget. 2016 Dec 21. doi: 10.18632/oncotarget.14078. [Epub ahead of print] Review.

8.

Is diffuse idiopathic skeletal hyperostosis a disease or a syndrome? Need for studies on angiogenesis-stimulating activity.

Pappone N, Ambrosino P, Di Minno MN, Iervolino S.

Rheumatology (Oxford). 2016 Dec 24. pii: kew451. doi: 10.1093/rheumatology/kew451. [Epub ahead of print] No abstract available.

PMID:
28013194
9.

Safety of warfarin in "high-risk" populations: A meta-analysis of randomized and controlled trials.

Di Minno MN, Ambrosino P, Dentali F.

Thromb Res. 2017 Feb;150:1-7. doi: 10.1016/j.thromres.2016.12.005.

PMID:
27988374
10.

Impact of body weight on the achievement of minimal disease activity in patients with rheumatic diseases: a systematic review and meta-analysis.

Lupoli R, Pizzicato P, Scalera A, Ambrosino P, Amato M, Peluso R, Di Minno MN.

Arthritis Res Ther. 2016 Dec 13;18(1):297.

11.

The risk of venous thromboembolism in patients with hepatitis C. A systematic review and meta-analysis.

Ambrosino P, Tarantino L, Criscuolo L, Nasto A, Celentano A, Di Minno MN.

Thromb Haemost. 2016 Oct 28;116(5):958-966.

PMID:
27411407
12.

Markers of atherosclerosis in patients with Cushing's syndrome: a meta-analysis of literature studies.

Lupoli R, Ambrosino P, Tortora A, Barba L, Lupoli GA, Di Minno MN.

Ann Med. 2016 Nov 18:1-11. [Epub ahead of print]

PMID:
27763781
13.

The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis.

Ambrosino P, Tarantino L, Di Minno G, Paternoster M, Graziano V, Petitto M, Nasto A, Di Minno MN.

Thromb Haemost. 2017 Jan 5;117(1):139-148. doi: 10.1160/TH16-06-0450.

PMID:
27761574
14.
15.

Markers of subclinical atherosclerosis in patients with aortic valve sclerosis: A meta-analysis of literature studies.

Di Minno MN, Di Minno A, Songia P, Ambrosino P, Gripari P, Ravani A, Pepi M, Rubba PO, Medda E, Tremoli E, Baldassarre D, Poggio P.

Int J Cardiol. 2016 Nov 15;223:364-370. doi: 10.1016/j.ijcard.2016.08.122.

PMID:
27543711
16.

The risk of coronary artery disease and cerebrovascular disease in patients with hepatitis C: A systematic review and meta-analysis.

Ambrosino P, Lupoli R, Di Minno A, Tarantino L, Spadarella G, Tarantino P, Nasto A, Celentano A, Di Minno MN.

Int J Cardiol. 2016 Oct 15;221:746-54. doi: 10.1016/j.ijcard.2016.06.337.

PMID:
27428315
17.

Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis.

Gentile M, Peluso R, Di Minno MN, Costa L, Caso F, de Simone B, Iannuzzo G, Scarpa R, Rubba P.

Clin Rheumatol. 2016 Aug;35(8):2023-9. doi: 10.1007/s10067-016-3344-4.

PMID:
27411815
18.

Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.

Napolitano M, Di Minno MN, Batorova A, Dolce A, Giansily-Blaizot M, Ingerslev J, Schved JF, Auerswald G, Kenet G, Karimi M, Shamsi T, Ruiz de Sáez A, Dolatkhah R, Chuansumrit A, Bertrand MA, Mariani G.

Haemophilia. 2016 Sep;22(5):752-9. doi: 10.1111/hae.12978.

PMID:
27338009
19.

Impact of Valve Morphology on the Prevalence of Coronary Artery Disease: A Systematic Review and Meta-Analysis.

Poggio P, Cavallotti L, Songia P, Di Minno A, Ambrosino P, Mammana L, Parolari A, Alamanni F, Tremoli E, Di Minno MN.

J Am Heart Assoc. 2016 May 18;5(5). pii: e003200. doi: 10.1161/JAHA.116.003200.

20.

Aortic valve sclerosis as a marker of atherosclerosis: Novel insights from hepatic steatosis.

Di Minno MN, Di Minno A, Ambrosino P, Songia P, Tremoli E, Poggio P.

Int J Cardiol. 2016 Aug 15;217:1-6. doi: 10.1016/j.ijcard.2016.04.162.

PMID:
27164417
Items per page

Supplemental Content

Loading ...
Support Center